Twist Bioscience (TWST) Market Capitalization (2018 - 2026)

Twist Bioscience (TWST) has reported Market Capitalization for 9 consecutive years, with $6.4 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 191.26% year-over-year to $6.4 billion in Q2 2026; TTM through Jun 2026 was $6.4 billion, a 191.26% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, down 35.86% from the prior year.
• Market Capitalization was $6.4 billion for Q2 2026 at Twist Bioscience, up from $3.0 billion in the prior quarter.
• Over five years, Market Capitalization peaked at $6.4 billion in Q2 2026 and troughed at $861.1 million in Q1 2023.
• A 5-year average of $2.3 billion and a median of $2.1 billion in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization sank 69.99% in 2022 and surged 191.26% in 2026, its largest moves.
• Over 5 years, Market Capitalization stood at $1.3 billion in 2022, then jumped by 57.91% to $2.1 billion in 2023, then soared by 30.01% to $2.8 billion in 2024, then retreated by 29.8% to $1.9 billion in 2025, then surged by 231.75% to $6.4 billion in 2026.
• The last three Market Capitalization figures came in at $6.4 billion (Q2 2026), $3.0 billion (Q1 2026), and $1.9 billion (Q4 2025), per Business Quant data.